JWJacek Wolf

Jacek Wolf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jacek Wolf has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of Microvascular Disturbances in Children with Type 1 Diabetes—A Pilot Study

    by Anna Wołoszyn-Durkiewicz, Edyta Dąbrowska, Marcin Hellmann, Anna Jankowska, Mariusz J. Kujawa, Dominik Świętoń, Agata Durawa, Joanna Kuhn, Joanna Szypułowska-Grzyś, Agnieszka Brandt-Varma, et al.

    Endothelial dysfunction appears early in type 1 diabetes (T1D). The detection of the first vascular disturbances in T1D patients is crucial, and the introduction of novel techniques, such as flow-mediated skin fluorescence (FMSF) and adaptive optics retinal camera (Rtx) imaging, gives hope for better detection and prevention of angiopathies in the future. In this study, we aimed to investigate microcirculation disturbances in pediatric patients with T1D with the use of FMSF and Rtx imaging. This research focused especially on the relationship between microvascular parameters obtained in FMSF and Rtx measurements, and the glycemic control evaluated in continuous glucose monitoring (CGM) reports. We observed significantly increased wall thickness (WT) and wall-to-lumen ratio (WLR) values in T1D patients in comparison to the control group. Although we did not observe significant differences between the T1D and control groups in the FMSF results, a trend toward significance between the time in range (TIR) and hyperemic response (HRmax) and an interesting correlation between the carotid intima-media thickness (cIMTmax) and HRmax. were observed. In conclusion, FMSF and Rtx measurments are innovative techniques enabling the detection of early microvascular disturbances.


  • Subclinical macroangiopathic target organ damage in type 1 diabetes mellitus patients

    by Magdalena Błaszkowska, Anna Shalimova, Bogumił Wolnik, Elżbieta Orłowska-Kunikowska, Beata Graff, Michał Hoffmann, Peter Nilsson, Jacek Wolf, Krzysztof Narkiewicz

    Purpose: We have summarized key studies regarding the assessment of subclinical macroangiopathic target organ damage (TOD) in type 1 diabetes mellitus (T1DM). Results: Although chronic complications resulting from hyperglycemia, in particular macroangiopathies, are still the first cause of death in T1DM, there has been growing recognition of the role of hypoglycemia in cardiovascular morbidity and mortality. Subclinical TOD diagnosis ensures early implementation of the complex management aiming at either partial reversal of these complications or at least its downturn. To better identify patients with early TODs, several non-invasive diagnostic techniques are employed, including the ultrasonographic assessment of the intima-media thickness (IMT), computed tomography (CT) for coronary artery calcium (CAC) scores, and pulse wave velocity (PWV) measurement for arterial stiffness evaluation. Various studies reported that T1DM patients present an increased IMT. An increasing IMT fairly correlates with the cardiovascular (CV) events risk even after the adjustment to age, diabetes duration, quality of glucose control as well as the presence of hypertension, and chronic complications. Another, well established marker of the organ damage – CAC score is recommended by ACC/AHA guidelines to assess the overall CV risk in T1DM. Also, the arterial stiffness evaluation with PWV may further improve CV risk prediction, which has been reported in multiple studies including the Framingham Heart Study. Conclusions: There is shortage of data from prospective studies which could confirm the benefits of early treatment initiation based on the presence of the subclinical organ damage in T1DM. Most evidence comes from T2DM trials, where effective preventive measures were identified i.e.: smoking cessation, reasonable blood glucose control, efficacious hypertension treatment, and dyslipidemia management, as well as renoprotection. There is still a field for further research to see if routine assessment of asymptomatic vascular damage and early implementation of aggressive treatment would reduce mortality excess from CVD in T1DM.


  • A response to “Cardiovascular disease and obstructive sleep apnea: an underappreciated role for increased platelet activity?”

    by Jacek Wolf, Krzysztof Narkiewicz

    (2018). A response to “Cardiovascular disease and obstructive sleep apnea: an underappreciated role for increased platelet activity?”. Expert Opinion on Pharmacotherapy: Vol. 19, No. 11, pp. 1165-1165.


  • Prevalence and characteristics of OSAFED syndrome in atrial fibrillation primary care patients

    by Jacek Wolf, Tadeusz Dereziński, Anna Szyndler, Krzysztof Narkiewicz

    Background: Atrial fibrillation (AF) constitutes the most prevalent arrhythmia affecting up-to 2% percent of general population. Apart from well-established risk factors which increase the odds for the development of AF e.g. age or arterial hypertension, recent analyses indicated that obstructive sleep apnea (OSA) may independently, negatively modify arrhythmia occurrence profile. Concurrently, erectile dysfunction (ED) is commonly neglected, potent marker of cardiovascular risk which considerably worsens men’s psychological state. Unrecognized, and untreated ED results in substantial deterioration of patient’s therapeutic program adherence. Owing to the fact that AF, OSA and ED share multiple risk factors and clinical consequences, in 2013 concept of their frequent concurrence - the OSAFED syndrome was proposed . Aim: The aim of the study was to evaluate the prevalence of OSAFED patients with atrial fibrillation in primary care practice. Methods: Retrospective analysis of data from primary care physician charts, NZOZ Esculap Gniewkowo, central Poland, including 1372 men aged 40-65. The primary goal was to determine the diagnosis of paroxysmal and/or permanent atrial fibrillation, which was followed by sleep apnea screening (polygraphy) and erectile function evaluation (IIED-5 questionnaire). Results: 21 patients (1.5%) with documented AF were identified. Based on the sleep-polygraphic studies 14 (67%) of them had the confirmation of OSA with mean apnea-hypopnea index equal to 27.5±17.1 (mean ±SD). Furthermore, eleven patients (52%) met OSAFED syndrome criteria. Patients with OSAFED syndrome had the mean score in IIEF-5 of 11.6 ±3.5. The OSAFED-patients who were not diagnosed with all the of the syndrome components prior to the study-enrollment were characterized by substantially lower fat excess comparing to their counterparts with already established OSAFED (BMI=30.1 ±4.9 vs. 37.7 ±3.9 kg/m2; respectively; P=0.03). Conclusions: Frequently coexisting OSAFED syndrome components in all AF patients from primary care setting should encourage more active search of OSA and ED in patients with documented any form of atrial fibrillation. Most of the studied patients did not have the diagnosis of OSA nor ED done prior to the participation in the study. Background: Atrial fibrillation (AF) constitutes the most prevalent arrhythmia affecting up-to 2% percent of general population. Apart from well-established risk factors which increase the odds for the development of AF e.g. age or arterial hypertension, recent analyses indicated that obstructive sleep apnea (OSA) may independently, negatively modify arrhythmia occurrence profile. Concurrently, erectile dysfunction (ED) is commonly neglected, potent marker of cardiovascular risk which considerably worsens men’s psychological state. Unrecognized, and untreated ED results in substantial deterioration of patient’s therapeutic program adherence. Owing to the fact that AF, OSA and ED share multiple risk factors and clinical consequences, in 2013 concept of their frequent concurrence - the OSAFED syndrome was proposed . Aim: The aim of the study was to evaluate the prevalence of OSAFED patients with atrial fibrillation in primary care practice. Methods: Retrospective analysis of data from primary care physician charts, NZOZ Esculap Gniewkowo, central Poland, including 1372 men aged 40-65. The primary goal was to determine the diagnosis of paroxysmal and/or permanent atrial fibrillation, which was followed by sleep apnea screening (polygraphy) and erectile function evaluation (IIED-5 questionnaire). Results: 21 patients (1.5%) with documented AF were identified. Based on the sleep-polygraphic studies 14 (67%) of them had the confirmation of OSA with mean apnea-hypopnea index equal to 27.5±17.1 (mean ±SD). Furthermore, eleven patients (52%) met OSAFED syndrome criteria. Patients with OSAFED syndrome had the mean score in IIEF-5 of 11.6 ±3.5. The OSAFED-patients who were not diagnosed with all the of the syndrome components prior to the study-enrollment were characterized by substantially lower fat excess comparing to their counterparts with already established OSAFED (BMI=30.1 ±4.9 vs. 37.7 ±3.9 kg/m2; respectively; P=0.03). Conclusions: Frequently coexisting OSAFED syndrome components in all AF patients from primary care setting should encourage more active search of OSA and ED in patients with documented any form of atrial fibrillation. Most of the studied patients did not have the diagnosis of OSA nor ED done prior to the participation in the study.


  • Effect of beta-blocker therapy on heart rate response in patients with hypertension and newly diagnosed untreated obstructive sleep apnea syndrome

    by Jacek Wolf, Jacek Drozdowski, Krzysztof Czechowicz, Paweł J. Winklewski, Ewa Jassem, Tomas Kara, Virend K. Somers, Krzysztof Narkiewicz


  • Erectile Dysfunction and Sleep Apnea

    by Jacek Wolf, Krzysztof Narkiewicz


  • Theophylline Therapy for Cheyne-Stokes Respiration During Sleep in a 41-Year-Old Man With Refractory Arterial Hypertension

    by Jacek Wolf, Ewa Świerblewska, Hanna Jasiel-Wojculewicz, Krzysztof Gockowski, Bogdan Wyrzykowski, Virend K. Somers, Krzysztof Narkiewicz


  • Obstructive Sleep Apnea

    by Jacek Wolf, Krzysztof Narkiewicz